company background image

Christina Lake Cannabis CNSX:CLC Stock Report

Last Price


Market Cap







10 Aug, 2022


Company Financials
CLC fundamental analysis
Snowflake Score
Future Growth0/6
Past Performance0/6
Financial Health5/6

CLC Stock Overview

Christina Lake Cannabis Corp. engages in growing, harvesting, processing, and selling cannabis products in the British Columbia, Canada.

Christina Lake Cannabis Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Christina Lake Cannabis
Historical stock prices
Current Share PriceCA$0.15
52 Week HighCA$0.50
52 Week LowCA$0.12
1 Month Change20.00%
3 Month Change0%
1 Year Change-66.29%
3 Year Changen/a
5 Year Changen/a
Change since IPO-67.74%

Recent News & Updates

Shareholder Returns

CLCCA PharmaceuticalsCA Market

Return vs Industry: CLC matched the Canadian Pharmaceuticals industry which returned -66.8% over the past year.

Return vs Market: CLC underperformed the Canadian Market which returned -2% over the past year.

Price Volatility

Is CLC's price volatile compared to industry and market?
CLC volatility
CLC Average Weekly Movement33.8%
Pharmaceuticals Industry Average Movement13.1%
Market Average Movement10.8%
10% most volatile stocks in CA Market19.4%
10% least volatile stocks in CA Market4.3%

Stable Share Price: CLC is more volatile than 90% of Canadian stocks over the past 3 months, typically moving +/- 34% a week.

Volatility Over Time: CLC's weekly volatility has increased from 18% to 34% over the past year.

About the Company

2014n/aMark Aiken

Christina Lake Cannabis Corp. engages in growing, harvesting, processing, and selling cannabis products in the British Columbia, Canada. It offers cannabis oil, hemp oil, and other hemp and cannabis derived products, as well as distillate oils. The company was formerly known as Cervantes Capital Corp. and changed its name to Christina Lake Cannabis Corp. in December 2018.

Christina Lake Cannabis Fundamentals Summary

How do Christina Lake Cannabis's earnings and revenue compare to its market cap?
CLC fundamental statistics
Market CapCA$19.48m
Earnings (TTM)-CA$3.81m
Revenue (TTM)CA$7.33m


P/S Ratio


P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
CLC income statement (TTM)
Cost of RevenueCA$5.88m
Gross ProfitCA$1.44m
Other ExpensesCA$5.25m

Last Reported Earnings

May 31, 2022

Next Earnings Date


Earnings per share (EPS)-0.029
Gross Margin19.71%
Net Profit Margin-51.95%
Debt/Equity Ratio47.7%

How did CLC perform over the long term?

See historical performance and comparison
We’ve recently updated our valuation analysis.


Is CLC undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score


Valuation Score 0/6

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for CLC?

Other financial metrics that can be useful for relative valuation.

CLC key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue3.3x
Enterprise Value/EBITDA-10.1x
PEG Ration/a

Price to Sales Ratio vs Peers

How does CLC's PS Ratio compare to its peers?

CLC PS Ratio vs Peers
The above table shows the PS ratio for CLC vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPSEstimated GrowthMarket Cap
Peer Average2.1x
AUSA Australis Capital
YOUR YourWay Cannabis Brands
NDVA Indiva
XTRX Adastra Holdings
CLC Christina Lake Cannabis

Price-To-Sales vs Peers: CLC is expensive based on its Price-To-Sales Ratio (2.7x) compared to the peer average (2.1x).

Price to Earnings Ratio vs Industry

How does CLC's PE Ratio compare vs other companies in the CA Pharmaceuticals Industry?

Price-To-Sales vs Industry: CLC is expensive based on its Price-To-Sales Ratio (2.7x) compared to the Canadian Pharmaceuticals industry average (1.8x)

Price to Sales Ratio vs Fair Ratio

What is CLC's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CLC PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio2.7x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate CLC's Price-To-Sales Fair Ratio for valuation analysis.

Share Price vs Fair Value

What is the Fair Price of CLC when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate CLC's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate CLC's fair value for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Future Growth

How is Christina Lake Cannabis forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score


Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


Forecasted Pharmaceuticals & Biotech industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Christina Lake Cannabis has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Discover growth companies

  • Examine Christina Lake Cannabis's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  • Christina Lake Cannabis competitive advantages and company strategy can generally be found in its financial reports archived here.

Past Performance

How has Christina Lake Cannabis performed over the past 5 years?

Past Performance Score


Past Performance Score 0/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: CLC is currently unprofitable.

Growing Profit Margin: CLC is currently unprofitable.

Past Earnings Growth Analysis

Earnings Trend: CLC is unprofitable, and losses have increased over the past 5 years at a rate of 54.5% per year.

Accelerating Growth: Unable to compare CLC's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: CLC is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (72.5%).

Return on Equity

High ROE: CLC has a negative Return on Equity (-32.1%), as it is currently unprofitable.

Discover strong past performing companies

Financial Health

How is Christina Lake Cannabis's financial position?

Financial Health Score


Financial Health Score 5/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Stable Cash Runway

  • Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: CLC's short term assets (CA$8.7M) exceed its short term liabilities (CA$1.2M).

Long Term Liabilities: CLC's short term assets (CA$8.7M) exceed its long term liabilities (CA$5.0M).

Debt to Equity History and Analysis

Debt Level: CLC's net debt to equity ratio (37.1%) is considered satisfactory.

Reducing Debt: Insufficient data to determine if CLC's debt to equity ratio has reduced over the past 5 years.

Balance Sheet

Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: CLC has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: CLC has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 44.5% each year

Discover healthy companies


What is Christina Lake Cannabis's current dividend yield, its reliability and sustainability?

Dividend Score


Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Cash Flow Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate CLC's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate CLC's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if CLC's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if CLC's dividend payments have been increasing.

Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as CLC has not reported any payouts.

Discover strong dividend paying companies


How experienced are the management team and are they aligned to shareholders interests?


Average management tenure


Mark Aiken

no data


Mr. Mark Aiken serves as Vice President of Sales at Plombco Inc. He began his career in sales positions with organizations to include Rema Tip Top AG, Vortex Aquatic Structures. From 2014 through 2019 Aike...

Leadership Team

Experienced Management: CLC's management team is not considered experienced ( 1.6 years average tenure), which suggests a new team.

Board Members

Experienced Board: CLC's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.


Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 12.9%.

Top Shareholders

Company Information

Christina Lake Cannabis Corp.'s employee growth, exchange listings and data sources

Key Information

  • Name: Christina Lake Cannabis Corp.
  • Ticker: CLC
  • Exchange: CNSX
  • Founded: 2014
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Implied Market Cap: CA$19.484m
  • Shares outstanding: 129.89m
  • Website:

Number of Employees


  • Christina Lake Cannabis Corp.
  • 789 West Pender Street
  • Suite 810
  • Vancouver
  • British Columbia
  • V6C 1H2
  • Canada


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/08/10 00:00
End of Day Share Price2022/08/10 00:00
Annual Earnings2021/11/30

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.